Skip to content

Psilocybin: all studies

Page 264 of 440: studies 2,631 to 2,640 of 4,392, newest first. Back to the psilocybin overview

Research

Richard Alpert (Ram Dass): Harvard psychologist who experimented with psychedelic drugs and became one of America’s most prominent and respected spiritual leaders

BMJ January 31, 2020 Rebecca Wallersteiner 1 citation

Credit: Dassima Kathleen Murphy Nothing in Richard Alpert’s early life could have predicted that he would come to embody the spirit of the psychedelic 1960s. He was born in Boston, Massachusetts, the youngest of three sons, to George and Gertrude (Levin) Alpert. His father, a prominent lawyer in Boston, was a founder of Brandeis University and went on to become president of the New York and New...

DOI: 10.1136/bmj.m407 (opens in new tab) Psilocybin Nothing Psychoanalysis Paranormal +1

Psychedelic therapy: Fresh promise for mental health

Mental Health Weekly January 24, 2020 Heidi Bush

Psychedelic‐assisted psychotherapy is seeing a resurgence as a treatment approach for mental health disorders. It melds pharmacology and psychotherapy, using substances such as lysergic acid diethylamide (LSD) and psilocybin, under medical supervision, to treat conditions such as post‐traumatic stress disorder (PTSD) and extreme depression.

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

Frontiers in Psychiatry January 22, 2020 Earth Erowid, Fire Erowid, Albert Garcia‐romeu et al. 155 citations

While these cross-sectional and self-report methods cannot determine whether psychedelics caused changes in drug use, results suggest the potential that psychedelics cause reductions in problematic substance use, and support additional clinical research on psychedelic-assisted treatment for SUD.

Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America

Journal of the History of Medicine and Allied Sciences January 13, 2020 Michael Draper 1 citation

Psychedelics are back in vogue. In popular culture, political legislation, and scientific research, we appear to be witnessing an early twenty-first century renaissance of the heady acid days of the 1960s. The success of Michael Pollan’s 2018 New York Times bestseller, How to Change Your Mind, the decriminalization of psilocybin-containing mushrooms in Denver in 2019, followed by all plant...

Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.

Journal of Psychoactive Drugs 2020 Samuli Kangaslampi, Aino Hausen, Tarina Rauteenmaa

Despite their acutely inebriating and sometimes unpleasant effects, some people report positive changes in life satisfaction, well-being, or mental health after taking psychedelic drugs. One explanation may be the ability of psychedelics to trigger mystical-type experiences. We examined the validity, reliability, and factor structure of a novel Finnish translation of the Revised Mystical...

Steroids, Dissociatives, Club Drugs, Inhalants, and Hallucinogens

Absolute Addiction Psychiatry Review 2020 Mashal Khan, Anil A. Thomas 3 citations

Anabolic-androgenic steroids, inhalants, hallucinogens, dissociative anesthetics and “club drugs” are a heterogeneous group of substances that have considerable potential for misuse and associated morbidity and/or mortality. Steroid use often goes undetected, even by addiction psychiatrists, though significant medical and psychiatric consequences often arise from chronic use. Inhalants, which...

Untersuchungen zur Biosynthese von Indolalkaloiden aus den Basidiomyceten der Gattung Psilocybe

Thüringer Universitäts- und Landesbibliothek 2020 Felix Blei

The goal of this doctoral thesis was the close examination of the biosynthesis of different indole alkaloides produced by different species of the fungal genus Psilocybe. This included the first characterization of the biosynthesis of psilocybin as the main psychotropic agent and the first discovery of the simultaneous production of β-carbolines. In the first step, the genome of P. cyanescens...

DOI: 10.22032/dbt.46039 (opens in new tab) Psilocybin Biosynthesis Biochemistry Gene cluster +2

Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017

Drug Science, Policy and Law 2020 Jec Anthony, Adam Winstock, Ja Ferris et al. 9 citations

It is well documented that psychedelic drugs can have a profound effect on colour perception. After previous research involving psychedelic drug ingestion, several participants had written to the authors describing how symptoms of their colour blindness had improved. The Global Drugs Survey runs the world’s largest annual online drug survey. In the Global Drugs Survey 2017, participants...

Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts

Drug Science, Policy and Law 2020 Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers 15 citations

Background It has been suggested that the outcome of the psychedelic experience is dependent on set and setting. While scientific research into the therapeutic potential of psychedelics is growing, it is clear that in clinical populations an optimal set and setting will not always be attainable. It was aimed to assess under which emotional and environmental circumstances psychedelic users use...

Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications

Journal of Music Therapy 2020 Clare O’callaghan, Daniel John Hubik, Justin Dwyer et al. 50 citations

Abstract Bonny Method of Guided Imagery and Music emerged following discontinuation of psychedelic therapy research in the early 1970s, but psychedelic therapy research has since revived. Music remains a vital component. This study examined participants’ experiences of music in psychedelic therapy research. A rapid review of qualitative and quantitative journal articles in four major databases...